Clinical Indications for Hyperbaric Oxygen Therapy

UHMS recommends considering adjunctive HBOT particularly in selected complex cases, including:

• Multiple intracranial abscesses
• Abscesses located deep within the brain
• Abscesses involving functionally important or dominant areas
• Immunocompromised patients
• Patients who are poor surgical candidates
• Situations in which surgery is contraindicated
• Continued deterioration despite appropriate antibiotics
• Failure to respond after surgical drainage or needle aspiration

The decision to use HBOT should be made in conjunction with neurosurgical, infectious-disease, and hyperbaric medicine teams.

HBOT as Part of Multidisciplinary Care

Intracranial abscess requires comprehensive treatment directed at controlling the infection and preventing neurologic injury.

Management may include:

• Intravenous antimicrobial therapy
• Neurosurgical aspiration or drainage
• Surgical excision in selected cases
• Identification and treatment of the primary infection source
• Seizure management
• Management of intracranial pressure
• Serial neurologic evaluation
• Repeat CT or MRI imaging

HBOT should be integrated into this treatment plan when appropriate rather than used as a stand-alone therapy.

Clinical and radiographic response should guide the overall duration of treatment.

Clinical Evidence and Guidelines

Intracranial abscess is recognized by the Undersea & Hyperbaric Medical Society as an accepted indication for adjunctive HBOT in selected patients.

The physiologic rationale includes increased oxygenation of hypoxic brain tissue, enhancement of leukocyte antimicrobial activity, inhibition of certain microorganisms, and reduction of cerebral edema.

The evidence base consists primarily of case reports, case series, retrospective studies, physiologic research, and accumulated clinical experience rather than randomized controlled trials.

A UHMS review concluded that the risk-benefit profile supports adjunctive HBOT in carefully selected patients, particularly those with multiple or surgically difficult abscesses, compromised immune function, contraindications to surgery, or deterioration despite standard surgical and antimicrobial treatment.

HBOT remains an adjunct and should not delay appropriate antimicrobial therapy or neurosurgical management.

Medicare Coverage

Although intracranial abscess is recognized by UHMS as an indication for adjunctive HBOT, it is not currently included among the covered conditions in Medicare National Coverage Determination 20.29.

CMS states that Medicare HBOT reimbursement is limited to the conditions specifically listed in the national coverage determination, and intracranial abscess is not included in that list.

Commercial insurance and Medicaid coverage may differ, so payer-specific requirements should be reviewed when HBOT is being considered.

When to Refer

Consider hyperbaric medicine consultation when a patient with intracranial abscess has:

• Multiple abscesses
• A deep or surgically difficult abscess
• Significant neurologic risk associated with surgical intervention
• Compromised immune function
• Contraindications to surgery
• Persistent infection despite appropriate antimicrobial therapy
• Continued deterioration despite drainage and antibiotics

HBOT should be considered an adjunct to appropriate neurosurgical and antimicrobial treatment, not a replacement for source control or definitive infection management.